Abstract
Purpose
To determine test characteristics of CT urography for detecting bladder cancer in patients with hematuria and those undergoing surveillance, and to analyze reasons for false-positive and false-negative results.
Methods
A HIPAA-compliant, IRB-approved retrospective review of reports from 1623 CT urograms between 10/2010 and 12/31/2013 was performed. 710 examinations for hematuria or bladder cancer history were compared to cystoscopy performed within 6 months. Reference standard was surgical pathology or 1-year minimum clinical follow-up. False-positive and false-negative examinations were reviewed to determine reasons for errors.
Results
Ninety-five bladder cancers were detected. CT urography accuracy: was 91.5% (650/710), sensitivity 86.3% (82/95), specificity 92.4% (568/615), positive predictive value 63.6% (82/129), and negative predictive value was 97.8% (568/581). Of 43 false positives, the majority of interpretation errors were due to benign prostatic hyperplasia (n = 12), trabeculated bladder (n = 9), and treatment changes (n = 8). Other causes include blood clots, mistaken normal anatomy, infectious/inflammatory changes, or had no cystoscopic correlate. Of 13 false negatives, 11 were due to technique, one to a large urinary residual, one to artifact. There were no errors in perception.
Conclusion
CT urography is an accurate test for diagnosing bladder cancer; however, in protocols relying predominantly on excretory phase images, overall sensitivity remains insufficient to obviate cystoscopy. Awareness of bladder cancer mimics may reduce false-positive results. Improvements in CTU technique may reduce false-negative results.
Similar content being viewed by others
References
Cancer Facts & Figures 2016 (2016) Atlanta: American Cancer Society. Accessed 2 Nov 2016
Shen L, Ramen S, Beland M, et al. (2014) ACR Appropriateness Criteria—Hematuria. American College of Radiology. https://acsearch.acr.org/docs/69490/Narrative/. Accessed 2 Nov 2016
Davis R, Jones JS, Barocas DA, et al. (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188:2473–2481
Heller MT, Tublin ME (2014) In search of a consensus: evaluation of the patient with hematuria in an era of cost containment. AJR Am J Roentgenol 202:1179–1186
McTavish JD, Jinzaki M, Zou KH, Nawfel RD, Silverman SG (2002) Multi-detector row CT urography: comparison of strategies for depicting the normal urinary collecting system. Radiology 225:783–790
Sadow CA, Silverman SG, O’Leary MP, Signorovitch JE (2008) Bladder cancer detection with CT urography in an Academic Medical Center. Radiology 249:195–202
Raman SP, Fishman EK (2014) Bladder malignancies on CT: the underrated role of CT in diagnosis. AJR Am J Roentgenol 203:347–354
Blick CG, Nazir SA, Mallett S, et al. (2012) Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic. BJU Int 110:84–94
Turney BW, Willatt JM, Nixon D, Crew JP, Cowan NC (2006) Computed tomography urography for diagnosing bladder cancer. BJU Int 98:345–348
Sudakoff GS, Dunn DP, Guralnick ML, et al. (2008) Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. J Urol 179:862–867
Chow LC, Sommer FG (2001) Multidetector CT urography with abdominal compression and three-dimensional reconstruction. AJR Am J Roentgenol 177:849–855
Grossfeld GD, Litwin MS, Wolf JS, et al. (2001) Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy—part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 57:604–610
Humphrey PA (2012) Urothelial carcinoma in situ of the bladder. J Urol 187:1057–1058
Park SB, Kim JK, Lee HJ, Choi HJ, Cho KS (2007) Hematuria: portal venous phase multi-detector row CT of the bladder—a prospective study. Radiology 245:798–805
Jinzaki M, Tanimoto A, Shinmoto H, et al. (2007) Detection of bladder tumors with dynamic contrast-enhanced MDCT. AJR Am J Roentgenol 188:913–918
Silverman SG, Akbar SA, Mortele KJ, et al. (2006) Multi-detector row CT urography of normal urinary collecting system: furosemide versus saline as adjunct to contrast medium. Radiology 240:749–755
Sadow CA, Wheeler SC, Kim J, Ohno-Machado L, Silverman SG (2010) Positive predictive value of CT urography in the evaluation of upper tract urothelial cancer. AJR Am J Roentgenol 195:W337–343
Shinagare AB, Sadow CA, Sahni VA, Silverman SG (2011) Urinary bladder: normal appearance and mimics of malignancy at CT urography. Cancer Imaging 11:100–108
Ren J, Huan Y, Wang H, et al. (2007) Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis. Clin Radiol 63:153–159
Shinagare AB, Silverman SG, Gershanik EF, Chang SL, Khorasani R (2014) Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis. Am J Med 127:625–632
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
None.
Rights and permissions
About this article
Cite this article
Trinh, T.W., Glazer, D.I., Sadow, C.A. et al. Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results. Abdom Radiol 43, 663–671 (2018). https://doi.org/10.1007/s00261-017-1249-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-017-1249-6